What makes the vital layer of protective cells around the brain and spinal cord—the blood-brain barrier—more or less permeable has been one of the more mystifying questions in neuroscience.
Jul 13, 2023
0
165
A team of scientists led by Nanyang Technological University, Singapore (NTU Singapore) has found that an existing cancer drug could be repurposed to target a subset of cancers that currently lack targeted treatment options ...
Jul 10, 2023
0
25
Hospitals participating in the 340B Drug Pricing Program, a large federal safety-net program, are financially incentivized to prescribe original biologic drugs to prevent and treat diseases in lieu of cheaper generic-like ...
Jun 21, 2023
0
6
The U.S. biosimilar drug market emerged in 2015 to provide safe, effective, and more affordable alternatives to existing biologic drugs, but it has been slow to develop compared with Europe.
Jun 6, 2023
0
1
Research at UC San Francisco has shown for the first time how the commonly prescribed seizure and pain medication, gabapentin, acts inside of cells, opening the door to new, more effective treatments for diseases like epilepsy ...
May 31, 2023
0
87
In the five years since the FDA's initial approval of chimeric antigen receptor (CAR) T cell therapy, Penn Medicine has gleaned 20 additional approvals related to drugs and techniques to treat or detect cancer.
May 29, 2023
0
33
For the first time, researchers described the structure of a special type of amyloid beta plaque protein associated with Alzheimer's disease (AD) progression. In a report published May 10 in the journal Neuron, scientists ...
May 10, 2023
0
92
A new University of Kentucky Markey Cancer Center study reveals more about changes that happen to cancer cells when they metastasize and identifies a promising target for the treatment of metastatic breast cancer.
May 9, 2023
0
21
What makes some cancer cells stay put while others break loose and spread through the body? A new study of C. elegans worms may hold some clues. Researchers at Duke University have put together what they say is the first ...
May 4, 2023
0
19
A new study led by Cláudia C. Faria, researcher in the lab of João Taborda Barata at the Instituto de Medicina Molecular João Lobo Antunes (iMM, Lisbon) and neurosurgeon at the Centro Hospitalar Universitário Lisboa Norte ...
May 1, 2023
0
3
